App-safe HK / Shenzhen ops
All targets
MediumBiomanufacturing55

Marubi Biotech

丸美生物技术股份有限公司

A listed Guangzhou skincare company that has built real recombinant-collagen and fermentation R&D (500+ patents) around barrier repair and anti-ageing — a science-led GBA player to learn from, though access for a small partner may be harder.

Location
Guangzhou Science City, Huangpu · Guangzhou
Visit window
Day-trip from Shenzhen · Weeks 2–4
Source status
medium confidencecandidate

Next action

Keep the dossier ready and use the open questions if a visit window opens.

Why now: Visit window · Day-trip from Shenzhen · Weeks 2–4

What they do

Guangdong Marubi Biotechnology (founded 2002, Shanghai-listed 2019) started in eye care and expanded into recombinant collagen and clinically-oriented functional skincare. It develops 'Triple Helix' recombinant collagen for higher biocompatibility versus animal-derived collagen and has published peer-reviewed work on recombinant dual-humanised collagen for anti-skin-ageing.

It reports 500+ patents (by 2025) and operates biotech subsidiaries — Guangzhou Huike Biotech and Guangzhou Cheer-Derm Biotech — co-located in the Guangzhou Science City area.

Why it matters

Medium — strong on science, lower on accessibility, and a secondary-line peer rather than a lead fit. As a listed skincare-science company, its recombinant-collagen, barrier-repair and peptide-delivery focus maps onto the Coolvex topical line's skin-repair and delivery themes and offers a useful biomanufacturing/fermentation benchmark, but with its own pipelines it is unlikely to act as a contract CDMO; the realistic angle is ingredient sourcing (via Huike/Cheer-Derm), delivery know-how or a strategic conversation.

Visit objective & route

Explore recombinant-collagen ingredient sourcing (via Huike/Cheer-Derm) and delivery-system know-how for the Coolvex topical line, and benchmark the fermentation/recombinant-protein R&D; a strategic/benchmark conversation rather than pilot manufacturing.

Approach route

Warm intro / program network; target R&D and ingredient subsidiaries (Huike / Cheer-Derm); Guangzhou day-trip.

Talking points

  • Do the Huike or Cheer-Derm subsidiaries sell your Triple Helix recombinant collagen externally as an ingredient?
  • Is there openness to a delivery-system / barrier-repair co-development with an external founder, or is access ingredient-sourcing only?
  • Which team is the right BD / ingredient contact (Marubi vs Huike vs Cheer-Derm) and which Science City site to visit?
  • Bring: Pure Advance one-pager; NDA template.

Open questions

  • Whether Huike / Cheer-Derm sell recombinant collagen externally as an ingredient.
  • Confirm a usable BD / ingredient contact route and the exact Science City site.
  • Verify the registered Chinese entity name and current site details.
  • Assess realistic openness to an external pilot/partnership before committing a day-trip.

Risks & unknowns

  • As a listed consumer brand with its own pipelines, unlikely to act as a contract fermentation CDMO.
  • Access for a small partner may be harder; realistic angle is ingredient sourcing / know-how, not pilot manufacturing.
  • No public BD contact confirmed; approach needs a warm intro.

Private-pack boundary

Contact details, exact address, and appointment logistics are kept in your private pack — verify privately before outreach. This dossier holds public, app-safe intelligence only.